Does UnitedHealthcare Cover Januvia?
The verdict
Covered on most plans
Yes — UnitedHealthcare covers Januvia for type 2 diabetes across commercial, ACA, Medicare, and Medicaid, managed through OptumRx, typically as a Tier 3 preferred brand. On Medicare, prior authorization and step therapy are generally low for Januvia. On UHC commercial plans, a metformin-first step therapy via the OptumRx Step Therapy program is common for DPP-4 inhibitors. The 2026 IRA negotiated Maximum Fair Price is $113 per 30-day supply — the largest percentage discount of the negotiated drugs. Generic sitagliptin (Sandoz, May 2026) is now available. The $2,100 annual Part D cap protects Medicare enrollees.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with UnitedHealthcare using your member ID.
Key facts
The 2026 IRA Maximum Fair Price for Januvia is $113 per 30-day supply — a 79% reduction from the prior list price of approximately $527, the largest percentage discount among all IRA Round 1 negotiated drugs.
CMS Medicare Drug Price Negotiation Program, 2026 MFP
Generic sitagliptin (Januvia's generic) launched May 2026 (Sandoz), available through OptumRx network pharmacies. Brand Januvia retails at approximately $700; generic sitagliptin is approximately $110 with a coupon.
Sandoz press release, May 26, 2026; GoodRx pricing data
UnitedHealthcare manages prescription benefits through OptumRx, which runs a Step Therapy program that commonly requires a metformin-first step for DPP-4 inhibitors like Januvia on commercial plans — verify your specific plan.
OptumRx Step Therapy program documentation; UHC plan benefit guides
Medicare vs. commercial coverage
Whether UnitedHealthcare covers Januvia depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Januvia is covered on UnitedHealthcare's Medicare Advantage and Part D plans (Advantage 3-Tier PDL), typically as a Tier 3 preferred brand. Prior authorization and step therapy are generally low on Medicare for Januvia — this is consistent with the low-UM pattern for DPP-4s in the Medicare channel. As a Part D sponsor, UnitedHealthcare must apply the IRA negotiated Maximum Fair Price of $113 per 30-day supply, effective January 1, 2026 — a 79% reduction from the prior list price of approximately $527, the largest percentage discount among IRA Round 1 drugs. The 2026 Part D $2,100 annual out-of-pocket cap limits total Medicare exposure. Note: the coinsurance-shift caveat applies — the MFP is a payer-side ceiling, and your actual cost depends on whether your UHC plan uses a fixed copay or coinsurance. LIS/Extra Help enrollees pay $0–$12.65 per month. Medicare beneficiaries cannot use the Merck $5 copay card. Note: do not confuse Januvia with Janumet (sitagliptin/metformin combination), which has a 2027 IRA MFP timeline.
Commercial / Employer
Group & marketplace plans
UnitedHealthcare's commercial and ACA plans, managed through OptumRx, cover Januvia for type 2 diabetes. The key commercial nuance is the OptumRx Step Therapy program: metformin-first step therapy is common for DPP-4 inhibitors on UHC commercial plans. If step therapy is required, your prescriber must document prior metformin use at the maximum tolerated dose or a clinical contraindication (for example, severe renal impairment) before Januvia is approved. ACA plans via UHC may also carry a step-therapy requirement. UHC Community Plan Medicaid covers Januvia; metformin-first step therapy and prior authorization are common per state Preferred Drug Lists, with typical cost-share of $0–$10. Generic sitagliptin (launched May 2026 by Sandoz) is now available through OptumRx network pharmacies and may appear on a lower tier, offering significant cost savings. Brand Januvia retails at approximately $696–$721, while generic sitagliptin is approximately $110 with a coupon. The Merck $5 copay card is available for commercially insured patients not enrolled in government programs; verify with your plan.
The 3 boxes you must tick to get approved
Commercial plans that will consider Januvia require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Januvia actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Brand Januvia: approximately $696–$721 per 30-day supply at retail pharmacy (pharmacy-variable estimate). Generic sitagliptin: approximately $110 with a coupon (pharmacy-variable estimate — launched May 2026).
List price with no coverage — before any manufacturer savings card.
With coverage
Medicare Part D/Advantage (UHC): IRA Maximum Fair Price $113 per 30-day supply effective January 1, 2026; typical Tier 3 cost-share; $2,100 annual out-of-pocket cap; LIS/Extra Help $0–$12.65 per month. Commercial: Merck $5 copay card (commercially insured only, not government-insured). Medicaid: $0–$10 typical. All figures are estimates — verify with your specific UHC plan.
Typical monthly copay once prior authorization is approved.
All dollar figures are estimates. Your actual cost depends on your UHC plan's tier structure, deductible status, and benefit phase. The MFP of $113 is a payer-side ceiling — your copay depends on whether your plan uses a fixed copay or coinsurance. Generic sitagliptin (launched May 2026) may offer significant cost savings through a lower OptumRx tier. Medicare beneficiaries cannot use the Merck $5 copay card. Do not confuse Januvia with Janumet (combination product with a 2027 IRA timeline). Confirm cost-share on the OptumRx formulary for your specific plan.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Look up Januvia and generic sitagliptin on the OptumRx or UHC formulary tool
Visit myuhc.com or the OptumRx formulary search for your 2026 plan. Search for both 'Januvia' and 'sitagliptin' to see if generic sitagliptin is on a lower tier. Confirm any step-therapy requirements, your estimated cost-share, and whether your plan uses a fixed copay or coinsurance for Tier 3 drugs.
- 2
Ask your prescriber to document metformin history if on commercial or Medicaid
If you are on a UHC commercial or Medicaid plan, a metformin-first step-therapy requirement through the OptumRx Step Therapy program is common for Januvia. Ask your prescriber to document prior metformin use (dose, duration, and reason for stopping or contraindication) with the prescription to resolve the step-therapy requirement efficiently.
- 3
Call UHC member services to confirm your tier, step-therapy, and deductible status
Call the number on the back of your UHC ID card. Ask: (1) Is Januvia or generic sitagliptin on my OptumRx formulary, and on which tier? (2) Does the OptumRx Step Therapy program apply to Januvia on my plan? (3) Is prior authorization required? (4) Has my annual deductible been met? Have your plan ID and medication dosage ready.
Options if UnitedHealthcare won't cover Januvia
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Generic sitagliptin
Generic sitagliptin (Januvia's generic, launched May 2026 by Sandoz) is now available through OptumRx network pharmacies. Brand Januvia retails at approximately $696–$721, while generic sitagliptin is approximately $110 with a coupon. Generics typically appear on a lower OptumRx tier, potentially Tier 1 or 2. Discuss with your prescriber whether switching to the generic is clinically appropriate.
Jardiance (empagliflozin)
An SGLT2 inhibitor for T2D, heart failure, and CKD. The 2026 IRA negotiated price is $197 per 30-day supply. On UHC commercial plans, commercial step therapy for Jardiance is also common (38.9% nationally). No generic available. Discuss with your prescriber whether an SGLT2 or DPP-4 fits your needs.
Farxiga (dapagliflozin) or generic dapagliflozin
Another SGLT2 inhibitor for T2D, heart failure, and CKD. Generic dapagliflozin is available. The 2026 IRA negotiated price for Farxiga is $178.50 per 30-day supply. OptumRx commercial step therapy for Farxiga is very common (45.8% nationally). Discuss clinical appropriateness with your prescriber.
Metformin (generic)
First-line oral diabetes medication; Tier 1 at approximately $4 per month cash price. If the OptumRx Step Therapy program requires metformin first, your prescriber will document this before approving Januvia.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Yes — UnitedHealthcare covers Januvia for type 2 diabetes across commercial, ACA, Medicare, and Medicaid via OptumRx, typically as a Tier 3 preferred brand. On Medicare, prior authorization is generally low for Januvia. On UHC commercial plans, metformin-first step therapy through the OptumRx Step Therapy program is common. The 2026 IRA negotiated price is $113 per 30-day supply. Generic sitagliptin launched in May 2026.
CMS negotiated a Januvia Maximum Fair Price of $113 per 30-day supply, effective January 1, 2026 — a 79% reduction from the prior list price of approximately $527, the largest percentage discount among IRA Round 1 drugs. All UHC Part D plans must apply this price. Your actual copay depends on your plan's tier structure and whether it uses a fixed copay or coinsurance. The $2,100 annual Part D out-of-pocket cap limits total Medicare exposure.
On UHC Medicare plans, a metformin-first step for Januvia is generally not expected — Medicare prior auth and step therapy for Januvia are low. On UHC commercial plans, metformin-first step therapy through the OptumRx Step Therapy program is common for DPP-4 inhibitors. Your prescriber can resolve this by documenting prior metformin use at the maximum tolerated dose or a clinical contraindication. Verify your specific plan on the OptumRx formulary.
Generic sitagliptin (launched May 2026 by Sandoz) should now be available through OptumRx network pharmacies and on UHC formularies. Generics typically appear on a lower tier than the brand — potentially Tier 1 or 2 — significantly reducing your cost-share. Brand Januvia retails at approximately $696–$721, while generic sitagliptin is approximately $110 with a coupon. Check the OptumRx formulary for your specific plan's generic sitagliptin tier.
Both Januvia (DPP-4) and Jardiance (SGLT2) are covered by UnitedHealthcare via OptumRx. Januvia has a 2026 IRA negotiated price of $113 versus Jardiance at $197. Generic sitagliptin is now available for Januvia; no generic exists for Jardiance. Commercial step therapy applies to both, but Jardiance's step rate is higher (38.9% commercially). The main clinical difference is that SGLT2 inhibitors have cardiovascular and kidney benefits beyond T2D — discuss with your prescriber which is appropriate.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Anthem Cover Contrave? 2026 Brand Coverage Guide | Curex
Anthem covers Contrave only if your plan has a weight-loss benefit. Many plans carve it out. CurAccess ~$99/mo is often the fastest path.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with UnitedHealthcare before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.